Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
3.

Central monoamine dysfunction in diabetes: psychotherapeutic implications: electroanalysis by voltammetry.

Broderick PA, Jacoby JH.

Acta Physiol Pharmacol Latinoam. 1989;39(3):211-25.

PMID:
2534495
4.

Cerebral taurine transport is increased during streptozocin-induced diabetes in rats.

Trachtman H, Futterweit S, Sturman JA.

Diabetes. 1992 Sep;41(9):1130-40.

PMID:
1386821
5.

Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia.

Chan O, Inouye K, Akirav EM, Park E, Riddell MC, Matthews SG, Vranic M.

Am J Physiol Regul Integr Comp Physiol. 2005 Jul;289(1):R235-46.

6.

Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats.

Chu PC, Lin MT, Shian LR, Leu SY.

Diabetes. 1986 Apr;35(4):481-5.

PMID:
3514326
7.

Dopaminergic system modulation of nociceptive response in long-term diabetic rats.

Rutledge LP, Ngong JM, Kuperberg JM, Samaan SS, Soliman KF, Kolta MG.

Pharmacol Biochem Behav. 2002 Dec;74(1):1-9.

PMID:
12376147
8.

Diabetes-related changes in L-tryptophan-induced release of striatal biogenic amines.

Broderick PA, Jacoby JH.

Diabetes. 1988 Jul;37(7):956-60.

PMID:
3384190
9.

Contrasting effects of acute insulin infusion on renal function in awake nondiabetic and diabetic rats.

Tucker BJ, Mendonca MM, Blantz RC.

J Am Soc Nephrol. 1993 Apr;3(10):1686-93.

10.
11.

Metabolic and neurochemical profiles in insulin-treated diabetic rats.

Bellush LL, Reid SG.

Am J Physiol. 1994 Jan;266(1 Pt 2):R87-94.

PMID:
7508209
12.

Involvement of Ca2+/calmodulin-dependent protein kinase II in the modulation of indolamines in diabetic and hyperglycemic rats.

Ramakrishnan R, Prabhakaran K, Jayakumar AR, Gunasekaran P, Sheeladevi R, Suthanthirarajan N.

J Neurosci Res. 2005 May 15;80(4):518-28.

PMID:
15846780
13.

Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.

Broderick PA, Hope O, Okonji C, Rahni DN, Zhou Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):157-71.

PMID:
14687870
15.

The Influence of hyperactivity of the hypothalamic-pituitary-adrenal axis and hyperglycemia on the 5-HT2A receptor-mediated wet-dog shake responses in rats.

Umeda Y, Amano M, Suemaru K, Yamaguchi T, Kitamura Y, Gomita Y, Kawasaki H, Araki H.

Acta Med Okayama. 2007 Dec;61(6):311-7.

16.
17.

Modulation by catecholamine of hypothalamus-pituitary-adrenocortical (HPA) axis activity in morphine-tolerance and withdrawal.

Martinez-Pi├▒ero MG, Milanes MV, Vargas ML.

Gen Pharmacol. 1994 Jan;25(1):187-92.

PMID:
8026704
18.
19.

Relative weight of glucose, insulin and parathyroid hormone in the urinary loss of phosphate by chronically diabetic rats.

Locatto ME, Di Loreto V, Fernández MC, Caferra D, Puche RC.

Acta Diabetol. 1997 Oct;34(3):211-6.

PMID:
9401643
20.

Ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats.

Shimomura Y, Shimizu H, Takahashi M, Uehara Y, Kobayashi I, Kobayashi S.

Exp Clin Endocrinol. 1990 Aug;95(3):385-8.

PMID:
2147142

Supplemental Content

Support Center